The risk to the general public from bird flu is low, and there has been no further evidence of person to person spread, ...

The widening U.S. bird flu outbreak has made its way to Maryland, which has counted two cases on commercial poultry farms — ...

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...

The US Food and Drug Administration said it is tracking multiple cases of H5N1 bird flu in domestic and wild cats, including ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine as concerns about a bird flu pandemic in humans ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.

As fears grow of a possible bird flu pandemic in humans, the federal government is pouring more money into the development of new vaccines, including an mRNA shot.

HHS is investing more than $800 million in vaccine development and manufacturing capacity to strengthen the nation's response capabilities to emerging infectious disease threats, including bird flu.

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

Mutations in one of the first human-isolated strains of H5N1 bird flu in the US were identified by the Texas Biomedical ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.